Centre for Individualised Infection Medicine

11.0k citations
434 papers ·

Impact in

    • SARS-CoV-2 and COVID-19 Research
    • COVID-19 Clinical Research Studies
    • Immune Cell Function and Interaction
    • Immune responses and vaccinations

Papers in

    • Hepatitis C virus research 44
    • Immune Cell Function and Interaction 44
    • Immune responses and vaccinations 40
    • T-cell and B-cell Immunology 28

Centre for Individualised Infection Medicine

368 papers receiving 9.6k citations

Peers

Centre for Individualised Infection Medicine
Comparison fields: 5 of 179
  • Infectious Diseases 2.8k
  • Immunology 3.0k
  • Hepatology 1.0k
  • Biological Psychiatry 148
  • Epidemiology 1.9k
Replace GlaxoSmithKline (Germany) with:
GlaxoSmithKline (Germany) Germany
Euroimmun Medizinische Labordiagnostika (Germany) Germany
Paul Langerhans Institute Dresden Germany
Miltenyi Biotec (Germany) Germany
Janssen (Switzerland) Switzerland
Biogen (Switzerland) Switzerland
Pfizer (Germany) Germany
Newron Pharmaceuticals (Italy) Italy
Synlab (Germany) Germany
Clinica Luganese Moncucco Switzerland
Centre for Individualised Infection Medicine relative to GlaxoSmithKline (Germany) Germany GlaxoSmithKline (Germany)'s profile →
Citations per field
00.5×2×3.3×
GlaxoSmithKline (Germany) · 1×
Citations per year

Countries citing scholars working at Centre for Individualised Infection Medicine

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at Centre for Individualised Infection Medicine. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Centre for Individualised Infection Medicine with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Centre for Individualised Infection Medicine more than expected).

Fields of papers published by authors at Centre for Individualised Infection Medicine

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers affiliated with Centre for Individualised Infection Medicine at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with Centre for Individualised Infection Medicine at the time of their publication.

About Centre for Individualised Infection Medicine

In recent decades, authors affiliated with Centre for Individualised Infection Medicine have published 434 papers, which have received a total of 11.0k indexed citations . Scholars at this organization have produced 76 papers in Hepatology, 118 papers in Immunology, 93 papers in Infectious Diseases, 108 papers in Epidemiology and 10 papers in Virology on the topics of SARS-CoV-2 and COVID-19 Research (52 papers), Hepatitis B Virus Studies (44 papers), Hepatitis C virus research (44 papers), Immune Cell Function and Interaction (44 papers), COVID-19 Clinical Research Studies (41 papers), Immune responses and vaccinations (40 papers), Liver Disease Diagnosis and Treatment (36 papers) and T-cell and B-cell Immunology (28 papers). Their work is cited by papers focused on Infectious Diseases (2.8k citations), Immunology (3.0k citations), Hepatology (1.0k citations), Biological Psychiatry (148 citations) and Epidemiology (1.9k citations). Authors at Centre for Individualised Infection Medicine collaborate with scholars in Germany, Netherlands and United States and have published in prestigious journals including Frontiers in Immunology, Nature Communications, Journal of Hepatology, Scientific Reports and iScience. Some of Centre for Individualised Infection Medicine's most productive authors include Markus Cornberg, Tim D. Sparwasser, Matthias Lochner, Luciana Berod, Immo Prinz, Michael Meyer‐Hermann, Yang Li, Luka Čičin‐Šain, Till Strowig and Michael Peter Manns.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore institutions with similar magnitude of impact